ScION Tech Growth I (SCOA) 10-K/A 11 Jan 22 2020 FY Annual report (amended) Financial data

Document And Entity Information

Document And Entity Information - USD ($)	3 Months Ended
	Dec. 31, 2020	Jan. 10, 2022	Jun. 30, 2020
Document Information Line Items
Entity Registrant Name	ScION Tech Growth I
Document Type	10-K/A
Current Fiscal Year End Date	--12-31
Entity Public Float			$ 593,400,000
Amendment Flag	true
Amendment Description	ScION Tech Growth I (the “Company”, “we”, “our” or “us”) is filing this Amendment No. 2 (this “Second Amendment”) to the Annual Report on Form 10-K/A (the “Restatement”) to amend the Annual Report on Form 10-K  for the year ended December 31, 2020, originally filed with the U.S. Securities and Exchange Commission (the “SEC”) on March 31, 2021 (the “Original Filing”) and amended on May 17, 2021 (the “First Amendment”), as a comprehensive amendment to amend and restate its financial statements and related footnote disclosures included in the Original Filing and the First Amendment as of and for the period ended December 31, 2020.Background of RestatementAll of the shares held by the Company’s public shareholders (the “Public Shares” or the “public shares”) contain a redemption feature which provides each holder of such shares with the opportunity to have their shares redeemed, and management has no control over which Public Shares will be redeemed. Accounting Standards Codification (“ASC”) 480-10-S99-3A “Distinguishing Liabilities from Equity” provides that redemption provisions not solely within the control of the issuer require shares subject to redemption to be classified outside of permanent equity. Furthermore, ASC 480-10-25-6(b) provides guidance stating that in determining if an instrument is mandatorily redeemable, a provision that defers redemption until a specified liquidity level is reached would not affect classification of the instrument. As such, management has identified errors made in the historical financial statements where, at the closing of the Company’s initial public offering, the Company improperly valued its common stock subject to possible redemption. The Company previously determined the ordinary shares subject to possible redemption to be equal to the redemption value, while also taking into consideration that a redemption cannot result in net tangible assets being less than $5,000,001. Management determined that the Public Shares can be redeemed or become redeemable subject to the occurrence of future events considered to be outside of the Company’s control. Therefore, management concluded that all ordinary shares subject to possible redemption value should be carried at redemption value as temporary equity outside of shareholders’ equity. As a result of this error, management has concluded that temporary equity and permanent equity as of and for the period ended December 31, 2020, should be restated in this Second Amendment (see Note 2). Subsequent reporting periods were restated in the Company’s Quarterly Report on Form 10-Q filed with the SEC on November 15, 2021. These restatements result in a change in the initial carrying value of the ordinary shares subject to possible redemption with the offset recorded to additional paid-in capital (to the extent available), accumulated deficit and ordinary shares. Further, as a result of this Second Amendment, there is no impact to the reported amounts for total assets, total liabilities, cash flows, or net income (loss); however, earnings per share was impacted due to a change in presentation relating to the restatements.The financial information that has been previously filed or otherwise reported for this period is superseded by the information in this Second Amendment, and the financial statements and related financial information contained in the Original Filing and the First Amendment should no longer be relied upon. On November 15, 2021, the Company filed a report on Form 8-K disclosing the non-reliance on the financial statements included in the Original Filing and the First Amendment.
Entity Central Index Key	0001828985
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Filer Category	Non-accelerated Filer
Entity Well-known Seasoned Issuer	No
Document Period End Date	Dec. 31, 2020
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	FY
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Shell Company	true
Entity Ex Transition Period	false
Document Transition Report	false
Entity File Number	001-39808
Entity Incorporation, State or Country Code	E9
Entity Interactive Data Current	Yes
Class A Ordinary Shares
Document Information Line Items
Entity Common Stock, Shares Outstanding		57,500,000
Class B Ordinary Shares
Document Information Line Items
Entity Common Stock, Shares Outstanding		14,375,000

Balance Sheet

Balance Sheet	Dec. 31, 2020USD ($)
Assets
Current asset - Cash	$ 1,425,919
Prepaid assets	936,986
Total current assets	2,362,905
Cash and securities held in Trust Account	575,009,968
Total Assets	577,372,873
Current liabilities:
Accrued offering costs and expenses	956,417
Due to related party	5,162
Total current liabilities	961,579
Warrant liability	30,461,667
Deferred underwriting discount	20,125,000
Total liabilities	51,548,246
Commitments
Class A ordinary shares subject to possible redemption, 57,500,000 shares at redemption value	575,009,968
Shareholders’ Deficit:
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding
Class A ordinary shares, $0.0001 par value; 500,000,000 shares authorized; no shares issued and outstanding (excluding 57,500,000 shares subject to possible redemption)
Class B ordinary shares, $0.0001 par value; 50,000,000 shares authorized; 14,375,000 shares issued and outstanding	1,438
Additional paid-in capital
Accumulated deficit	(49,186,779)
Total shareholders’ deficit	(49,185,341)
Total Liabilities and Shareholders’ Deficit	$ 577,372,873

Balance Sheet (Parentheticals)

Balance Sheet (Parentheticals)	Dec. 31, 2020$ / sharesshares
Preference shares, par value (in Dollars per share) | $ / shares	$ 0.0001
Preference shares, shares authorized	5,000,000
Preference shares, shares issued
Preference shares, shares outstanding
Class A Ordinary Shares
Ordinary shares, subject to possible redemption	57,500,000
Ordinary shares par value (in Dollars per share) | $ / shares	$ 0.0001
Ordinary shares, authorized	500,000,000
Ordinary shares, shares issued
Ordinary shares, shares outstanding
Class B Ordinary Shares
Ordinary shares par value (in Dollars per share) | $ / shares	$ 0.0001
Ordinary shares, authorized	50,000,000
Ordinary shares, shares issued	14,375,000
Ordinary shares, shares outstanding	14,375,000

Statement of Operations

Statement of Operations	3 Months Ended
	Dec. 31, 2020USD ($)$ / sharesshares
Income Statement [Abstract]
Formation and operating costs	$ 35,790
Loss from operations	(35,790)
Other income (expense)
Warrant issuance costs	(816,060)
Unrealized loss on change in fair value of warrants	(3,675,000)
Interest Income	9,968
Total other expense	(4,481,092)
Net loss	$ (4,516,882)
Basic and diluted weighted average shares outstanding, ordinary shares subject to redemption (in Shares) | shares	6,764,706
Basic and diluted net loss per share (in Dollars per share) | $ / shares	$ (0.23)
Basic and diluted weighted average shares outstanding, ordinary shares (in Shares) | shares	12,720,588
Basic and diluted net loss per share (in Dollars per share) | $ / shares	$ (0.23)

Statement of Changes in Stockho

Statement of Changes in Stockholders’ Equity Deficit - 3 months ended Dec. 31, 2020 - USD ($)	Class AOrdinary Shares	Class BOrdinary Shares	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at Oct. 06, 2020
Balance (in Shares) at Oct. 06, 2020
Class B ordinary shares issued to Sponsor		$ 1,438	23,562		25,000
Class B ordinary shares issued to Sponsor (in Shares)		14,375,000
Excess of cash received over fair value of the Private Placement Warrants			6,480,000		6,480,000
Initial classification of warrant liability			(5,200,000)		(5,200,000)
Remeasurement of Class A ordinary shares to possible redemption value			(1,303,562)	(44,669,897)	(45,973,459)
Net loss				(4,516,882)	(4,516,882)
Balance at Dec. 31, 2020		$ 1,438		$ (49,186,779)	$ (49,185,341)
Balance (in Shares) at Dec. 31, 2020		14,375,000

Statement of Cash Flows

Statement of Cash Flows	3 Months Ended
	Dec. 31, 2020USD ($)
Cash Flows from Operating Activities:
Net loss	$ (4,516,882)
Adjustments to reconcile net loss to net cash used in operating activities:
Interest earned on treasury securities held in Trust Account	(9,968)
Warrant issuance costs	816,060
Unrealized loss on change in fair value of warrants	3,675,000
Changes in current assets and current liabilities:
Prepaid assets	(936,986)
Due to related party	5,162
Accounts payable	956,417
Net cash used in operating activities	(11,197)
Cash Flows from Investing Activities:
Investment held in Trust Account	(575,000,000)
Net cash used in investing activities	(575,000,000)
Cash Flows from Financing Activities:
Proceeds from Initial Public Offering, net of underwriters’ fees	563,500,000
Proceeds from private placement	13,500,000
Proceeds from issuance of founder shares	25,000
Proceeds from issuance of promissory note to related party	222,583
Repayment of promissory note to related party	(222,583)
Payments of offering costs	(587,884)
Net cash provided by financing activities	576,437,116
Net Change in Cash	1,425,919
Cash - Beginning
Cash - Ending	1,425,919
Supplemental Disclosure of Non-cash Financing Activities:
Initial value of Class A ordinary shares subject to possible redemption	529,036,509
Change in value of Class A ordinary shares subject to possible redemption	45,973,459
Deferred underwriting commissions charged to additional paid-in capital	20,125,000
Initial classification of warrant liability	$ 26,786,667

Organization and Business Opera

Organization and Business Operations	3 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
Organization and Business Operations	Note 1 — Organization and Business Operations Organization and General ScION Tech Growth I (the “Company”) was incorporated as a Cayman Islands exempted company on October 7, 2020. The Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company is an “emerging growth company”, as defined in Section 2(a) of the Securities Act of 1933, as amended (the Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”). The Company’s efforts to identify a prospective target business will not be limited to a particular industry or geographic location. The Company has selected December 31 as its fiscal year end. As of December 31, 2020, the Company had not yet commenced any operations. All activity for the period from October 7, 2020 (inception) through December 31, 2020 relates to the Company’s formation and the Initial Public Offering (“IPO”) described below. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the IPO and will recognize changes in the fair value of warrant liability as other income (expense). Financing The registration statement for the Company’s IPO was declared effective on December 16, 2020 (the “Effective Date”). On December 21, 2020, the Company consummated the IPO of 57,500,000 units, including the issuance of 7,500,000 units as a result of the underwriters’ full exercise of the over-allotment option (the “Units” and, with respect to the ordinary shares included in the Units being offered, the “Public Shares” or the “public shares”), at $10.00 per Unit, generating gross proceeds of $575,000,000, which is discussed in Note 4. Simultaneously with the closing of the IPO, the Company consummated the sale of 9,000,000 warrants (the “Private Placement Warrants”) at a price of $1.50 per Private Placement Warrant in a private placement to the Sponsor, generating gross proceeds of $13,500,000, which is discussed in Note 5. Transaction costs amounted to $32,212,884 consisting of $11,500,000 of underwriting discount, $20,125,000 of deferred underwriting discount, and $587,884 of other offering costs. Trust Account Following the closing of the IPO on December 21, 2020, $575,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the IPO and the sale of the Private Placement Warrants was placed in a Trust Account, which can only be invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations. Except with respect to interest earned on the funds held in the Trust Account that may be released to the Company to pay its taxes, if any, the proceeds from the IPO and the sale of the Private Placement Warrants will not be released from the Trust Account until the earliest of (i) the completion of the Business Combination, (ii) the redemption of the Company’s Public Shares if the Company is unable to complete the initial Business Combination within 24 months from December 21, 2020 (the “Combination Period”), the closing of the IPO, subject to applicable law, or (iii) the redemption of the Company’s Public Shares properly submitted in connection with a shareholder vote to amend the Company’s amended and restated memorandum and articles of association. Initial Business Combination The Company’s management has broad discretion with respect to the specific application of the net proceeds of the IPO and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the value of the assets held in the Trust Account (excluding the deferred underwriting commissions and taxes payable on the interest earned on the Trust Account) at the time of the agreement to enter into the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act 1940, as amended (the “Investment Company Act”). There is no assurance that the Company will be able to complete a Business Combination successfully. The Company will provide its public shareholders with the opportunity to redeem all or a portion of their public shares upon the completion of the initial Business Combination either (i) in connection with a general meeting called to approve the initial Business Combination or (ii) without a shareholder vote by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a proposed initial Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The shareholders will be entitled to redeem their shares for a pro rata portion of the amount then on deposit in the Trust Account (initially $10.00 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its taxes). The shares of ordinary share subject to redemption will be recorded at a redemption value and classified as temporary equity upon the completion of the IPO, in accordance with Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 and, if the Company seeks shareholder approval, a majority of the issued and outstanding shares voted are voted in favor of the Business Combination. If the Company is unable to complete the initial Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account (less tax payable and up to $100,000 of interest to pay dissolution expenses) divided by the number of then outstanding public shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining shareholders and the Company’s board of directors, liquidate and dissolve, subject in the case of clauses (ii) and (iii) to the Company’s obligations under Cayman Islands law to provide for claims of creditors and in all cases subject to the other requirements of applicable law. The Sponsor, officers and directors have agreed to (i) waive their redemption rights with respect to their founder shares and public shares in connection with the completion of the initial Business Combination, (ii) waive their redemption rights with respect to their founder shares and public shares in connection with a shareholder vote to approve an amendment to the Company’s amended and restated memorandum and articles of association, (iii) waive their rights to liquidating distributions from the Trust Account with respect to their founder shares if the Company fails to complete the initial Business Combination within the Combination Period, and (iv) vote any founder shares held by them and any public shares purchased during or after the IPO (including in open market and privately-negotiated transactions) in favor of the initial Business Combination. On February 1, 2021, the Company announced that, commencing on February 5, 2021, the holders of Units may elect to separately trade the Class A ordinary shares and warrants included in the Units. The Units not separated will continue to trade on the NASDAQ Capital Market under the symbol “SCOAU.” Class A ordinary shares and warrants will separately trade on The Nasdaq Capital Market under the symbols “SCOA” and “SCOAW”, respectively. Liquidity and Capital Resources As of December 31, 2020, the Company had cash outside the Trust Account of $1,425,919 available for working capital needs. All remaining cash held in the Trust Account are generally unavailable for the Company’s use, prior to an initial Business Combination, and is restricted for use either in a Business Combination or to redeem ordinary shares. As of December 31, 2020, none of the amount in the Trust Account was available to be withdrawn as described above. Through December 31, 2020, the Company’s liquidity needs were satisfied through a capital contribution from the Sponsor of $25,000, to cover certain offering costs, for the founder shares (see Note 6), the loan under an unsecured promissory note from the Sponsor of $222,583 (see Note 6), and the net proceeds from the consummation of the Private Placement not held in the Trust Account. The promissory note from the Sponsor was paid in full on December 22, 2020. The Company anticipates that the $1,425,919 outside of the Trust Account as of December 31, 2020, will be sufficient to allow the Company to operate for at least the next 12 months, assuming that a Business Combination is not consummated during that time. Until consummation of its Business Combination, the Company will be using the funds not held in the Trust Account, and any additional Working Capital Loans (as defined in Note 6) from the initial shareholders, the Company’s officers and directors, or their respective affiliates (which is described in Note 6), for identifying and evaluating prospective acquisition candidates, performing business due diligence on prospective target businesses, traveling to and from the offices, plants or similar locations of prospective target businesses, reviewing corporate documents and material agreements of prospective target businesses, selecting the target business to acquire and structuring, negotiating and consummating the Business Combination. The Company does not believe it will need to raise additional funds in order to meet the expenditures required for operating its business. However, if the Company’s estimates of the costs of undertaking in-depth due diligence and negotiating Business Combination is less than the actual amount necessary to do so, the Company may have insufficient funds available to operate its business prior to the Business Combination. Moreover, the Company will need to raise additional capital through loans from its Sponsor, officers, directors, or third parties. None of the Sponsor, officers or directors are under any obligation to advance funds to, or to invest in, the Company. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of its business plan, and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. Risks and Uncertainties On January 30, 2020, the World Health Organization (“WHO”) announced a global health emergency because of a new strain of coronavirus (the “COVID-19 outbreak”). In March 2020, the WHO classified the COVID-19 outbreak as a pandemic, based on the rapid increase in exposure globally. The full impact of the COVID-19 outbreak continues to evolve. The impact of the COVID-19 outbreak on the Company’s financial position will depend on future developments, including the duration and spread of the outbreak and related advisories and restrictions. These developments and the impact of the COVID-19 outbreak on the financial markets and the overall economy are highly uncertain and cannot be predicted. If the financial markets and/or the overall economy are impacted for an extended period, the Company’s financial position may be materially adversely affected. Additionally, the Company’s ability to complete an initial Business Combination may be materially adversely affected due to significant governmental measures being implemented to contain the COVID-19 outbreak or treat its impact, including travel restrictions, the shutdown of businesses and quarantines, among others, which may limit the Company’s ability to have meetings with potential investors or affect the ability of a potential target company’s personnel, vendors and service providers to negotiate and consummate an initial Business Combination in a timely manner. The Company’s ability to consummate an initial Business Combination may also be dependent on the ability to raise additional equity and debt financing, which may be impacted by the COVID-19 outbreak and the resulting market downturn.

Restatement of previously issue

Restatement of previously issued financial statements	3 Months Ended
	Dec. 31, 2020
Condensed Financial Information Disclosure [Abstract]
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS	NOTE 2 — RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS First Amendment In April 2021, the Company concluded that, because of a misapplication of the accounting guidance related to its Public and Private Placement Warrants the Company issued in December 2020, the Company’s previously issued financial statements for the Affected Period should no longer be relied upon. As such, the Company is restating its financial statements for the Affected Period included in this Annual Report. On April 12, 2021, the SEC Statement was issued. Specifically, the SEC Statement focused on certain settlement terms and provisions related to certain tender offers following a Business Combination, which terms are similar to those contained in the warrant agreement, dated as of December 16, 2020, between the Company and Continental Stock Transfer & Trust Company, a New York corporation, as warrant agent (the “Warrant Agreement”). Historically, the Warrants were reflected as a component of equity as opposed to liabilities on the balance sheets and the statements of operations did not include the subsequent non-cash changes in estimated fair value of the Warrants, based on our application of ASC 815-40. The views expressed in the SEC Staff Statement were not consistent with the Company’s historical interpretation of the specific provisions within its Warrant Agreement and the Company’s application of ASC 815-40 to the warrant agreement. As a result of the SEC Statement, the Company reevaluated the accounting treatment of (i) the 19,166,667 Public Warrants, (ii) the 9,000,000 Private Placement Warrants, and (iii) the 6,666,667 Forward Purchase Warrants (See Note 4, Note 5 and Note 8). The Company previously accounted for all Warrants as components of equity. Based on this reassessment, management determined that the Warrants should be classified as liabilities measured at fair value upon issuance, with subsequent changes in fair value reported in the Company Statement of Operations each reporting period. Therefore, the Company’s management and the Audit Committee of the Company’s Board of Directors (the “Audit Committee”) concluded that, in light of the SEC Statement, (i) certain items on the Company’s previously issued audited balance sheet dated as of December 21, 2020 which was related to its initial public offering, and (ii) the Company’s previously issued audited financial statements for the Affected Periods included in the Company’s Annual Report should no longer be relied upon and that it is appropriate to restate the Annual Report. The Company will file an amendment to the Annual Report, which will include the restated audited financial statements for the Affected Periods. The Company has not amended its previously filed Current Report on Form 8-K for the Affected Periods. The financial information that has been previously filed or otherwise reported for these periods is superseded by the information in this Annual Report, and the financial statements and related financial information contained in such previously filed reports should no longer be relied upon. In further consideration of the guidance in ASC 815-40, Derivatives and Hedging; Contracts in Entity’s Own Equity, the Company concluded that a provision in the Warrant Agreement related to certain tender or exchange offers precludes the Warrants from being accounted for as components of equity. As the Warrants meet the definition of a derivative as contemplated in ASC 815, the Warrants should be recorded as derivative liabilities on the balance sheet and measured at fair value at inception (on the date of the IPO) and at each reporting date in accordance with ASC 820, Fair Value Measurement, with changes in fair value recognized in the statement of operations in the period of change. After consultation with the Company’s independent registered public accounting firm, the Company’s management and the audit committee of the Company’s Board of Directors concluded that it is appropriate to restate the Company’s previously issued audited financial statements for the Affected Periods, as previously reported in its Form 10-K. The restated classification and reported values of the Warrants as accounted for under ASC 815-40 are included in the financial statements herein. The following tables summarize the effect of the restatement on each financial statement line item as of the dates, and for the period, indicated: As Adjustment As Restated Balance Sheet at December 21, 2020 Warrant Liability $ - $ 26,786,667 $ 26,786,667 Class A ordinary shares subject to possible redemption 551,300,880 (26,786,670 ) 524,514,210 Class A ordinary shares 237 268 505 Additional paid-in capital 5,009,562 815,795 5,825,357 Accumulated deficit $ (11,233 ) $ (816,060 ) $ (827,293 ) Balance Sheet at December 31, 2020 Warrant Liability $ - $ 30,461,667 $ 30,461,667 Class A ordinary shares subject to possible redemption, 551,286,290 (30,461,670 ) 520,824,620 Class A ordinary shares 237 305 542 Additional paid-in capital 5,024,151 4,490,758 9,514,909 Accumulated deficit $ (25,822 ) $ (4,491,060 ) $ (4,516,882 ) Statement of Operations for the period from October 7, 2020 (inception) through December 31, 2020 Unrealized loss on change in fair value of warrants $ - $ (3,675,000 ) $ (3,675,000 ) Warrant issuance costs - (816,060 ) (816,060 ) Net loss $ (25,822 ) $ (4,491,060 ) $ (4,516,882 ) Weighted average shares outstanding, basic and diluted 14,653,813 315,137 14,968,950 Basic and diluted net loss per share $ (0.00 ) $ (0.30 ) $ (0.30 ) Statement of Cash Flows for the period from October 7, 2020 (inception) through December 31, 2020 Cash Flows from Operating Activities: Net loss $ (25,822 ) $ (4,491,060 ) $ (4,516,882 ) Unrealized loss on change in fair value of warrants - 3,675,000 3,675,000 Warrant issuance costs $ - $ 816,060 $ 816,060 Second Amendment In connection with the preparation of the Company’s financial statements as of September 30, 2021, the Company’s management determined it should restate its previously reported financial statements. The Company previously determined that the Public Shares subject to possible redemption were equal to their redemption value of $10.00 per Public Share while also taking into consideration the requirement under the Company’s amended and restated memorandum and articles of association that the Company’s redemption of Public Shares cannot result in the Company’s net tangible assets being less than $5,000,001. Upon review of its financial statements for the period ended September 30, 2021, the Company reevaluated the classification of the Public Shares and determined that the Public Shares can be redeemed or become redeemable subject to the occurrence of future events considered outside the Company’s control under ASC 480-10-S99. Therefore, the Company’s management concluded that the carrying value should include all Public Shares subject to possible redemption, resulting in all of the Public Shares being classified outside of permanent equity. As a result, management has noted a reclassification adjustment related to temporary equity and permanent equity. This resulted in an adjustment to the initial carrying value of the Public Shares with the offset recorded to additional paid-in capital (to the extent available), accumulated deficit and Public Shares. See Note 3, “Ordinary Shares Subject to Possible Redemption.” In connection with the change in presentation for the Public Shares, the Company also restated its earnings per share calculation to allocate net income (loss) evenly to the Public Shares and Class B ordinary shares. This presentation contemplates a Business Combination as the most likely outcome, in which case, both classes of ordinary shares share pro rata in the income (loss) of the Company. There has been no change in the Company’s total assets, liabilities or operating results. The impact of the restatement on the Company’s financial statements is reflected in the following table. As Adjustments As Restated Balance Sheet as of December 21, 2020 (as revised in footnote 2 per Form 10-K/A filed on May 17, 2021) Ordinary share subject to possible redemption ($) $ 524,514,210 $ 50,485,790 $ 575,000,000 Ordinary shares Class A, $0.0001 par value 505 (505 ) - Additional paid-in capital 5,825,357 (5,825,357 ) - Accumulated deficit (827,293 ) (44,659,928 ) (45,487,221 ) Total shareholders’ equity $ 5,000,007 $ (50,485,790 ) $ (45,485,783 ) Number of shares subject to redemption 52,451,421 5,048,579 57,500,000 Balance Sheet at December 31, 2020 Class A ordinary shares subject to possible redemption $ 520,824,620 $ 54,185,348 $ 575,009,968 Class A ordinary shares 542 (542 ) - Additional paid-in capital 9,514,909 (9,514,909 ) - Accumulated deficit (4,516,882 ) (44,669,897 ) (49,186,779 ) Total shareholders’ equity $ 5,000,007 $ (54,185,348 ) $ (49,185,341 ) Statement of Operations for the period from October 7, 2020 (inception) through December 31, 2020 Basic and diluted weighted average shares outstanding, ordinary shares subject to redemption - 6,764,706 6,764,706 Basic and diluted net loss per share $ - $ (0.23 ) $ (0.23 ) Basic and diluted weighted average shares outstanding, ordinary shares 14,968,950 (2,248,362 ) 12,720,588 Basic and diluted net loss per share $ (0.30 ) $ 0.07 $ (0.23 ) Statement of Shareholders’ Equity for the period from October 7, 2020 (inception) through December 31, 2020 Remeasurement in Class A ordinary shares to redemption value $ (520,824,620 ) $ 474,851,161 $ (45,973,459 ) Class A ordinary shares 542 (542 ) - Additional paid-in capital 9,514,909 (9,514,909 ) - Accumulated deficit (4,516,882 ) (44,669,897 ) (49,186,779 ) Total shareholders’ equity $ 5,000,007 $ (54,185,348 ) $ (49,185,341 ) Statement of Cash Flows for the period from October 7, 2020 (inception) through December 31, 2020 Initial value of Class A ordinary shares subject to possible redemption $ 524,514,210 $ 4,522,299 $ 529,036,509 Remeasurement in Class A ordinary shares to redemption value $ (3,689,590 ) $ 49,663,049 $ 45,973,459

Summary of Significant Accounti

Summary of Significant Accounting Policies	3 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Note 3 — Summary of Significant Accounting Policies Basis of Presentation The accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“US GAAP”) and pursuant to the rules and regulations of the SEC. As described in Note 2—Restatement of Previously Issued Financial Statements, the Company’s financial statements for the fiscal year ended December 31, 2020 are restated in this Annual Report on Form 10-K/A to change the Company’s accounting and reflect the full amount of all redeemable public shares in temporary equity. As a result of the change in presentation for the Class A ordinary shares subject to possible redemption, the Company has also restated its earnings per ordinary share calculation to allocate income and losses shared pro rata between the two classes of ordinary shares. The restated financial statements are indicated as “Restated” in the audited and unaudited condensed financial statements and accompanying notes, as applicable. See Note 2—Restatement of Previously Issued Financial Statements for further discussion. Emerging Growth Company Status The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended, (the “Securities Act”), as modified by the Jumpstart our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of December 31, 2020. Cash and Securities Held in Trust Account Securities held in Trust Account consist of United States Treasury securities. The Company classifies its United States Treasury securities as held-to-maturity in accordance with FASB ASC Topic 320 “Investments - Debt and Equity Securities.” Held-to-maturity securities are those securities which the Company has the ability and intent to hold until maturity. Held-to-maturity treasury securities are recorded at amortized cost and adjusted for the amortization or accretion of premiums or discounts. A decline in the market value of held-to-maturity securities below cost that is deemed to be other than temporary, results in an impairment that reduces the carrying costs to such securities’ fair value. The impairment is charged to earnings and a new cost basis for the security is established. To determine whether an impairment is other than temporary, the Company considers whether it has the ability and intent to hold the investment until a market price recovery and considers whether evidence indicating the cost of the investment is recoverable outweighs evidence to the contrary. Evidence considered in this assessment includes the reasons for the impairment, the severity and the duration of the impairment, changes in value subsequent to year-end, forecasted performance of the investee, and the general market condition in the geographic area or industry the investee operates in. Premiums and discounts are amortized or accreted over the life of the related held-to-maturity security as an adjustment to yield using the effective-interest method. Such amortization and accretion is included in the “interest income” line item in the statements of operations. Interest income is recognized when earned. Fair Value Measurements (Restated, see Note 2, First Amendment) FASB ASC Topic 820 “Fair Value Measurements and Disclosures” (“ASC 820”) defines fair value, the methods used to measure fair value and the expanded disclosures about fair value measurements. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between the buyer and the seller at the measurement date. In determining fair value, the valuation techniques consistent with the market approach, income approach and cost approach shall be used to measure fair value. ASC 820 establishes a fair value hierarchy for inputs, which represent the assumptions used by the buyer and seller in pricing the asset or liability. These inputs are further defined as observable and unobservable inputs. Observable inputs are those that buyer and seller would use in pricing the asset or liability based on market data obtained from sources independent of the Company. Unobservable inputs reflect the Company’s assumptions about the inputs that the buyer and seller would use in pricing the asset or liability developed based on the best information available in the circumstances. The fair value of the Public Warrants issued in connection with the initial public offering and Private Placement Warrants were initially measured at fair value using a Monte Carlo simulation model and subsequently, the fair value of the Private Placement Warrants have been estimated using a Monte Carlo simulation model each measurement date. The fair value of Public Warrants issued in connection with the initial public offering has been measured based on the listed market price of such warrants since February 5 th The fair value hierarchy is categorized into three levels based on the inputs as follows: Level 1 — Valuations based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. Valuation adjustments and block discounts are not being applied. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these securities does not entail a significant degree of judgment. Level 2 — Valuations based on (i) quoted prices in active markets for similar assets and liabilities, (ii) quoted prices in markets that are not active for identical or similar assets, (iii) inputs other than quoted prices for the assets or liabilities, or (iv) inputs that are derived principally from or corroborated by market through correlation or other means. Level 3 — Valuations based on inputs that are unobservable and significant to the overall fair value measurement. The fair value of the Company’s certain assets and liabilities, which qualify as financial instruments under ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the balance sheet. The fair values of cash and cash equivalents, prepaid assets, accounts payable and accrued expenses, due to related parties are estimated to approximate the carrying values as of December 31, 2020 due to the short maturities of such instruments. The Company’s warrant liability is based on a valuation model utilizing management judgment and pricing inputs from observable and unobservable markets with less volume and transaction frequency than active markets. Significant deviations from these estimates and inputs could result in a material change in fair value. The fair value of the warrant liability is classified as level 3. See Note 7 for additional information on assets and liabilities measured at fair value. Derivative Financial Instruments (Restated, see Note 2, First Amendment) The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging”. Derivative instruments are recorded at fair value on the grant date and re-valued at each reporting date, with changes in the fair value reported in the statements of operations. Derivative assets and liabilities are classified on the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date. The Company has determined the warrants are a derivative instrument. FASB ASC 470-20, Debt with Conversion and Other Options addresses the allocation of proceeds from the issuance of convertible debt into its equity and debt components. The Company applies this guidance to allocate IPO proceeds from the Units between Class A ordinary shares and warrants, using the residual method by allocating IPO proceeds first to fair value of the warrants and then the Class A ordinary shares. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. At December 31, 2020, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. Ordinary Shares Subject to Possible Redemption (Restated, see Note 2, Second Amendment) All of the 57,500,000 Public Shares contain a redemption feature which allows for their redemption in connection with the Company’s liquidation, if there is a shareholder vote or tender offer in connection with the Business Combination and in connection with certain amendments to the Company’s amended and restated memorandum and articles of association. In accordance with SEC and its staff’s guidance on redeemable equity instruments, which has been codified in ASC 480-10-S99, redemption provisions not solely within the control of the Company require ordinary shares subject to redemption to be classified outside of permanent equity. Therefore, all Public Shares have been classified outside of permanent equity. In accordance with ASC 480-10-S99-3A(15), there are two alternative methods that an entity can apply when subsequently measuring redeemable public shares: 1. Remeasure the redeemable public shares to their redemption amount immediately as if the end of the first reporting period after the IPO was the redemption date. 2. Accrete changes in the difference between the initial carrying amount and the redemption amount from the IPO date to the redemption date. The Company has decided to apply the first method above. As of December 31, 2020, the Class A ordinary shares reflected on the balance sheet are reconciled in the following table: Gross proceeds from IPO $ 575,000,000 Less: Proceeds allocated to Public Warrants (14,566,667 ) Class A ordinary shares issuance costs (31,396,824 ) Plus: Accretion of carrying value to redemption value 45,973,459 Class A ordinary shares subject to possible redemption $ 575,009,968 Net Loss Per Ordinary Share (Restated, see Note 2, Amendment 2) The Company has two classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Earnings and losses are shared pro rata between the two classes of shares. The 28,166,667 potential ordinary shares for outstanding warrants to purchase the Company’s shares were excluded from diluted earnings per share for the period from October 7, 2020 (inception) through December 31, 2020 because the warrants are contingently exercisable, and the contingencies have not yet been met. As a result, diluted net loss per ordinary share is the same as basic net loss per ordinary share for the period presented. The table below presents a reconciliation of the numerator and denominator used to compute basic and diluted net loss per share for each class of ordinary shares: For the period from Class A Class B Basic and diluted net loss per share: Numerator: Allocation of net loss $ (1,568,125 ) $ (2,948,757 ) Denominator: Weighted-average shares outstanding 6,764,706 12,720,588 Basic and diluted net loss per share $ (0.23 ) $ (0.23 ) Offering Costs The Company complies with the requirements of the ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A - “Expenses of Offering”. Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to the IPO. Offering costs are allocated to the separable financial instruments issued in the IPO based on a relative fair value basis compared to total proceeds received. Offering costs associated with warrant liabilities is expensed, and offering costs associated with the Class A ordinary share are charged to the shareholders’ equity. Income Taxes The Company accounts for income taxes under ASC 740 Income Taxes (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is a Cayman Islands exempted company and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. Recent Accounting Pronouncements Management does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.

Initial Public Offering

Initial Public Offering	3 Months Ended
	Dec. 31, 2020
Initial Public Offering [Abstract]
Initial Public Offering	Note 4 — Initial Public Offering Pursuant to the IPO, the Company sold 57,500,000 Units, including 7,500,000 Units as a result of the underwriters’ full exercise of the over-allotment option, at a price of $10.00 per Unit. Each Unit consists of one Class A ordinary share and one-third of one redeemable warrant. Each whole warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment. The warrants will become exercisable on the later of 30 days after the completion of the initial Business Combination or 12 months from the closing of the IPO, and will expire five years after the completion of the initial Business Combination or earlier upon redemption or liquidation. Warrants (Restated, see Note 2, Amendment 1) Each whole warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment as discussed herein. In addition, if (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination (excluding any issuance of forward purchase securities) at an issue price or effective issue price of less than $9.20 per Class A ordinary share (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and in the case of any such issuance to the Company’s initial shareholders or their affiliate, without taking into account any founder shares held by the Company’s initial shareholders or such affiliates, as applicable, prior to such issuance (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds (including from such issuances, the IPO and the sale of the forward purchase units), and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s Class A ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, then the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger prices described below under “Redemption of warrants when the price per Class A ordinary share equals or exceeds $18.00” and “Redemption of warrants when the price per Class A ordinary share equals or exceeds $10.00” will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price, and the $10.00 per share redemption trigger price described adjacent to the caption “Redemption of warrants when the price per Class A ordinary share equals or exceeds $10.00” will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price. The warrants will become exercisable on the later of 12 months from the closing of the IPO or 30 days after the completion of its initial Business Combination, and will expire five years after the completion of the Company’s initial Business Combination, at 5:00 p.m., New York City time, or earlier upon redemption or liquidation. The Company will not be obligated to deliver any Class A ordinary shares pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act with respect to Class A ordinary shares underlying the warrants is then effective and a prospectus relating thereto is current. No warrant will be exercisable and the Company will not be obligated to issue a Class A ordinary share upon exercise of a warrant unless the Class A ordinary share issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants. In no event will the Company be required to net cash settle any warrant. In the event that a registration statement is not effective for the exercised warrants, the purchaser of a unit containing such warrant will have paid the full purchase price for the unit solely for the Class A ordinary share underlying such unit. Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $18.00 Once the warrants become exercisable, the Company may redeem the outstanding warrants: ● in whole and not in part; ● at a price of $0.01 per warrant; upon a minimum of 30 days’ prior written notice of redemption (the “30-day redemption period”); and ● if, and only if, the closing price of the Class A ordinary shares equals or exceeds $18.00 per share, subject to adjustment, for any 20 trading days within a 30-trading day period ending three business days before the Company sends the notice of redemption to the warrant holders. Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $10.00 Once the warrants become exercisable, the Company may redeem the outstanding warrants: ● in whole and not in part; ● at a price of $0.10 per warrant; upon a minimum of 30 days’ prior written notice of redemption; provided ● if, and only if, the closing price of Class A ordinary shares equals or exceeds $10.00 per share, subject to adjustment, for any 20 trading days within the 30-trading day period ending three trading days before the Company sends the notice of redemption to the warrant holders; and ● if the closing price of the Class A ordinary shares for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders is less than $18.00 per share, subject to adjustment, the private placement warrants must also be concurrently called for redemption on the same terms as the outstanding public warrants, as described above. In addition, if a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants is not effective by the sixtieth (60th) business day after the closing of the initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding the above, if Class A ordinary shares are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of public warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, it will not be required to file or maintain in effect a registration statement, and in the event the Company does not so elect, it will use its best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. In such event, each holder would pay the exercise price by surrendering each such warrant for that number of shares of the Company’s Class A ordinary shares equal to the lesser of (A) the quotient obtained by dividing (x) the product of the number of Class A ordinary shares underlying the warrants, multiplied the excess of the “fair market value” over the exercise price of the warrants by (y) the fair market value and (B) 0.361. The “fair market value” shall mean the average reported closing price of the Class A ordinary shares for the 10 trading days ending on the third trading day prior to the date on which the notice of warrant exercise is sent to the warrant agent.

Private Placement

Private Placement	3 Months Ended
	Dec. 31, 2020
Private Placement Disclosure [Abstract]
Private Placement	Note 5 — Private Placement Simultaneously with the closing of the IPO, the Sponsor purchased an aggregate of 9,000,000 Private Placement Warrants at a price of $1.50 per Private Placement Warrant, for an aggregate purchase price of $13,500,000, in a private placement. The proceeds from the Private Placement Warrants was added to the proceeds from the IPO held in the Trust Account. The Private Placement warrants are identical to the warrants sold in the IPO, except that the Private Placement Warrants, so long as they are held by the Sponsor or its permitted transferees, (i) will not be redeemable by the Company, (ii) may not (including the Class A ordinary shares issuable upon exercise of these warrants), subject to certain limited exceptions, be transferred, assigned or sold by the holders until 30 days after the completion of the Company’s initial Business Combination, (iii) may be exercised by the holders on a cashless basis and (iv) will be entitled to certain registration rights. The Private Placement Warrants will be non-redeemable and exercisable on a cashless basis so long as they are held by the Sponsor. If the Private Placement Warrants are held by holders other than the Sponsor or its permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by the holders on the same basis as the warrants included in the units being sold in the IPO. The Sponsor has agreed to (i) waive its redemption rights with respect to its founder shares and public shares in connection with the completion of the initial Business Combination, (ii) waive its redemption rights with respect to its founder shares and public shares in connection with a shareholder vote to approve an amendment to the Company’s amended and restated memorandum and articles of association (A) to modify the substance or timing of the Company’s obligation to allow redemption in connection with the initial Business Combination or to redeem 100% of the Company’s public shares if the Company has not consummated its initial Business Combination within the Combination Period or (B) with respect to any other material provisions relating to shareholders’ rights or pre-initial Business Combination activity, (iii) waive its rights to liquidating distributions from the Trust Account with respect to its founder shares if the Company fails to complete its initial Business Combination within the Combination Period, and (iv) vote any founder shares held by the Sponsor and any public shares purchased during or after the IPO (including in open market and privately-negotiated transactions) in favor of the initial Business Combination.

Related Party Transactions

Related Party Transactions	3 Months Ended
	Dec. 31, 2020
Related Party Transactions [Abstract]
Related Party Transactions	Note 6 — Related Party Transactions Founder Shares On October 7, 2020, the Sponsor paid $25,000, or approximately $0.002 per share, to cover certain offering costs in consideration for 14,375,000 Class B ordinary shares, par value $0.0001 (the founder Shares). Up to 1,875,000 founder shares are subject to forfeiture by the Sponsor depending on the extent to which the underwriters’ over-allotment option is exercised. In connection with the underwriters’ full exercise of their over-allotment option on December 21, 2020, the 1,875,000 shares were no longer subject to forfeiture. The initial shareholders have agreed not to transfer, assign or sell any of their founder shares and any Class A ordinary shares issuable upon conversion thereof until the earlier to occur of: (i) one year after the completion of the initial Business Combination, or (ii) the date on which the Company completes a liquidation, merger, share exchange or other similar transaction after the initial Business Combination that results in all of the Company’s shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property; except to certain permitted transferees and under certain circumstances (the “lock-up”). Notwithstanding the foregoing, if (1) the closing price of Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the initial Business Combination or (2) if the Company consummates a transaction after the initial Business Combination which results in the Company’s shareholders having the right to exchange their shares for cash, securities or other property, the founder shares will be released from the lock-up. Promissory Note — Related Party On October 9, 2020, the Sponsor agreed to loan the Company up to $300,000 to be used for a portion of the expenses of the IPO. These loans are non-interest bearing, unsecured and are due at the earlier of December 31, 2021 or the closing of the IPO. The loan will be repaid upon the closing of the IPO out of the $1,000,000 of offering proceeds that has been allocated to the payment of offering expenses As of December 21, 2020, the Company had borrowed $222,583 under the promissory note. The promissory note from the Sponsor was paid in full on December 22, 2020. Due to Related Parties The balance of $5,162 represents the amount accrued for the administrative support services provided by Sponsor. Related Party Loans In order to finance transaction costs in connection with an intended Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes the initial Business Combination, the Company would repay the Working Capital Loans. In the event that the initial Business Combination does not close, the Company may use a portion of the working capital held outside the Trust Account to repay the Working Capital Loans but no proceeds from the Trust Account would be used to repay the Working Capital Loans. Up to $1,500,000 of such Working Capital Loans may be convertible into warrants at a price of $1.50 per warrant at the option of the lender. Such warrants would be identical to the Private Placement Warrants. As of December 31, 2020, the Company had no borrowings under the Working Capital Loans. Administrative Service Fee Commencing on the Effective Date of the registration statement, the Company has agreed to pay the Sponsor $10,000 per month for office space, utilities, secretarial and administrative support services provided to members of the Company’s management team. Upon completion of the initial Business Combination or the Company’s liquidation, the Company will cease paying these monthly fees. For the period from December 16, 2020 to December 31, 2020, the Company incurred $5,162 of administrative services under this arrangement. Upon completion of the initial Business Combination or the Company’s liquidation, the Company will cease paying these monthly fees. Forward Purchase Agreement On December 16, 2020, the Company entered into a forward purchase agreement pursuant to which an affiliate of the Sponsor committed that it will purchase from the Company 10,000,000 forward purchase units, or at its option up to an aggregate maximum of 30,000,000 forward purchase units, each consisting of one Class A ordinary share, or a forward purchase share, and one-third of one warrant (the “Forward Purchase Warrants”) to purchase one Class A ordinary share, or a forward purchase warrant, for $10.00 per unit, or an aggregate amount of $100,000,000, or at the purchaser’s option up to an aggregate amount of $300,000,000, in a private placement that will close concurrently with the closing of the Company’s initial Business Combination. The proceeds from the sale of these forward purchase units, together with the amounts available to the Company from the Trust Account (after giving effect to any redemptions of Public Shares) and any other equity or debt financing obtained by the Company in connection with the Business Combination, will be used to satisfy the cash requirements of the Business Combination, including funding the purchase price and paying expenses and retaining specified amounts to be used by the post-Business Combination company for working capital or other purposes. The forward purchase shares will be identical to the Class A ordinary shares included in the units being sold in the IPO, except that they will be subject to transfer restrictions and registration rights. The forward purchase warrants will have the same terms as the Private Placement Warrants so long as they are held by the purchaser or its permitted assignees and transferees.

Recurring Fair Value Measuremen

Recurring Fair Value Measurements	3 Months Ended
	Dec. 31, 2020
Fair Value Disclosures [Abstract]
Recurring Fair Value Measurements	Note 7 — Recurring Fair Value Measurements Cash and Securities Held in Trust Account As of December 31, 2020, investment in the Company’s Trust Account consisted of $632 in U.S. Money Market and $575,009,336 in U.S. Treasury Securities. All of the U.S. Treasury Securities mature on March 25, 2021. The Company classifies its United States Treasury securities as held-to-maturity in accordance with FASB ASC 320 “Investments — Debt and Equity Securities”. Held-to-maturity treasury securities are recorded at amortized cost and adjusted for the amortization or accretion of premiums or discounts. The Company considers all investments with original maturities of more than three months but less than one year to be short-term investments. The carrying value approximates the fair value due to its short-term maturity. The carrying value, excluding gross unrealized holding loss and fair value of held to maturity securities on December 31, 2020 are as follows: December 31, Quoted Significant Significant 2020 (Level 1) (Level 2) (Level 3) Assets: U.S. Money Market held in Trust Account $ 632 $ 632 $ - $ - U.S. Treasury Securities held in Trust Account 575,009,336 575,009,336 - - $ 575,009,968 $ 575,009,968 $ - $ - Liabilities: Private Placement Warrants 7,920,000 - - $ 7,920,000 Public Warrants 16,675,000 - - $ 16,675,000 Forward Purchase Warrants 5,866,667 - - $ 5,866,667 Warrant Liability $ 30,461,667 $ - $ - $ 30,461,667 Warrant Liability (Restated, see Note 2, Amendment 1) At December 31, 2020, the Company’s warrants liability were valued at $30,461,667. Under the guidance in ASC 815-40 the warrants do not meet the criteria for equity treatment. As such, the warrants must be recorded on the balance sheet at fair value. This valuation is subject to re-measurement at each balance sheet date. With each re-measurement, the warrant valuation will be adjusted to fair value, with the change in fair value recognized in the Company’s statement of operations. Recurring Fair Value Measurements (Restated, see Note 2, Amendment 1) The following table presents information about the Company’s assets and liabilities that were measured at fair value on a recurring basis as of December 31, 2020, and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value. December 31, Quoted Significant Significant 2020 (Level 1) (Level 2) (Level 3) Assets: U.S. Money Market held in Trust Account $ 632 $ 632 $ - $ - U.S. Treasury Securities held in Trust Account 575,009,336 575,009,336 - - $ 575,009,968 $ 575,009,968 $ - $ - Liabilities: Private Placement Warrants - - - $ 7,920,000 Public Warrants - - - $ 16,675,000 Forward Purchase Warrants - - - $ 5,866,667 $ 30,461,667 $ - $ - $ 30,461,667 Warrants (Restated, see Note 2, Amendment 1) The Warrants are accounted for as liabilities in accordance with ASC 815-40 and are presented within warrant liabilities on the Balance Sheet. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of warrant liabilities in the Statement of Operations. The mid-point of the Forward Purchase Agreement ($200 million) has been used as an estimate for the purpose of deriving the associated warrant liability. Initial Measurement (Restated, see Note 2, Amendment 1) The Company established the initial fair value for the Warrants on December 16, 2020, the date of the Company’s Initial Public Offering, using a Monte Carlo simulation model for the Public Warrants, and the Black-Sholes Model for Private Placement Warrants and Forward Purchase Warrants based on their relative fair values at the initial measurement date. The Warrants were classified as Level 3 at the initial measurement date due to the use of unobservable inputs. The key inputs into the Monte Carlo simulation model and Black-Scholes Model were as follows at initial measurement: Input December 16, Risk-free interest rate 0.47 % Expected term (years) 5.75 Expected volatility 15.0 % Exercise price $ 11.50 Subsequent Measurement (Restated, see Note 2, Amendment 1) The Warrants are measured at fair value on a recurring basis. At the subsequent measurement date of December 31, 2020, the Public Warrants were fair valued using the Monte Carlo Simulation Method, and the Private Placement Warrants and Forward Purchase Warrants were valued using the Black-Scholes Method. The fair value classification for the Public Warrants, Private Placement Warrants, and Forward Purchase Warrants remain unchanged as Level 3 from their initial valuation. The key inputs into the Monte Carlo simulation and Black Scholes model were as follows: Input December 31, Risk-free interest rate 0.46 % Expected term (years) 5.71 Expected volatility 15.0 % Exercise price $ 11.50 The following table presents the changes in the fair value of warrant liabilities: Public Warrants Public Warrants Forward Purchase Warrants Fair value as of December 31, 2019 - - - Initial measurement on December 16, 2020 $ 7,020,000 $ 14,566,667 $ 5,200,000 Change in valuation inputs or other assumptions (1) $ 900,000 $ 2,108,333 $ 666,667 Fair value as of December 31, 2020 $ 7,920,000 $ 16,675,000 $ 5,866,667 (1) Changes in valuation inputs or other assumptions are recognized in change in fair value of warrant liabilities in the Statement of Operations.

Commitments

Commitments	3 Months Ended
	Dec. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
Commitments	Note 8 — Commitments Registration Rights The holders of the founder shares, Private Placement Warrants, the forward purchase securities which will be issued in a private placement concurrently with the closing of the initial Business Combination and the Class A ordinary shares underlying such Private Placement Warrants and forward purchase securities, and Private Placement Warrants, forward purchase warrants and warrants that may be issued upon conversion of Working Capital Loans will have registration rights to require the Company to register a sale of any of its securities held by them pursuant to a registration rights agreement signed on December 16, 2020. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the Company’s completion of the initial Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The Company granted the underwriters a 45-day option from December 21, 2020 to purchase up to an additional 7,500,000 units to cover over-allotments. On December 21, 2020, the underwriters fully exercised the over-allotment option. On December 21, 2020, the Company paid a fixed underwriting discount of $11,500,000. Additionally, the underwriters will be entitled to a deferred underwriting discount of 3.5% of the gross proceeds of the IPO held in the Trust Account, or $20,125,000, upon the completion of the Company’s initial Business Combination.

Shareholders' Equity

Shareholders' Equity	3 Months Ended
	Dec. 31, 2020
Stockholders' Equity Note [Abstract]
Shareholders' Equity	Note 9 — Shareholders’ Equity (Restated, see Note 2, Amendment 2) Preference shares Class A Ordinary Shares Class B Ordinary Shares Holders of the Class A ordinary shares and holders of the Class B ordinary shares will vote together as a single class, with each share entitling the holder to one vote, on any other matter submitted to a vote of the Company’s shareholders, including any vote in connection with the Company’s initial Business Combination, except as required by law; provided that only holders of the Class B ordinary shares have the right to appoint directors in any election held prior to or in connection with the completion of the initial Business Combination. The Class B ordinary shares will automatically convert into Class A ordinary shares concurrently with or immediately following the consummation of the initial Business Combination on a one-for-one basis, subject to adjustment for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like, and subject to further adjustment as provided herein. In the case that additional Class A ordinary shares or equity-linked securities are issued or deemed issued in connection with the initial Business Combination, the number of Class A ordinary shares issuable upon conversion of all founder shares will equal, in the aggregate, 20% of the total number of Class A ordinary shares outstanding after such conversion (after giving effect to any redemptions of Class A ordinary shares by public shareholders), including the total number of Class A ordinary shares issued, or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial Business Combination (including the forward purchase shares but not the forward purchase warrants), excluding any Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, or to be issued, to any seller in the initial Business Combination and any Private Placement Warrants issued to the Sponsor, officers or directors upon conversion of Working Capital Loans; provided that such conversion of founder shares will never occur on a less than one-for-one basis.

Subsequent Events

Subsequent Events	3 Months Ended
	Dec. 31, 2020
Subsequent Events [Abstract]
Subsequent Events	Note 10 — Subsequent Events The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. The Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements.

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	3 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“US GAAP”) and pursuant to the rules and regulations of the SEC. As described in Note 2—Restatement of Previously Issued Financial Statements, the Company’s financial statements for the fiscal year ended December 31, 2020 are restated in this Annual Report on Form 10-K/A to change the Company’s accounting and reflect the full amount of all redeemable public shares in temporary equity. As a result of the change in presentation for the Class A ordinary shares subject to possible redemption, the Company has also restated its earnings per ordinary share calculation to allocate income and losses shared pro rata between the two classes of ordinary shares. The restated financial statements are indicated as “Restated” in the audited and unaudited condensed financial statements and accompanying notes, as applicable. See Note 2—Restatement of Previously Issued Financial Statements for further discussion.
Emerging Growth Company Status	Emerging Growth Company Status The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended, (the “Securities Act”), as modified by the Jumpstart our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of December 31, 2020.
Cash and Securities Held in Trust Account	Cash and Securities Held in Trust Account Securities held in Trust Account consist of United States Treasury securities. The Company classifies its United States Treasury securities as held-to-maturity in accordance with FASB ASC Topic 320 “Investments - Debt and Equity Securities.” Held-to-maturity securities are those securities which the Company has the ability and intent to hold until maturity. Held-to-maturity treasury securities are recorded at amortized cost and adjusted for the amortization or accretion of premiums or discounts. A decline in the market value of held-to-maturity securities below cost that is deemed to be other than temporary, results in an impairment that reduces the carrying costs to such securities’ fair value. The impairment is charged to earnings and a new cost basis for the security is established. To determine whether an impairment is other than temporary, the Company considers whether it has the ability and intent to hold the investment until a market price recovery and considers whether evidence indicating the cost of the investment is recoverable outweighs evidence to the contrary. Evidence considered in this assessment includes the reasons for the impairment, the severity and the duration of the impairment, changes in value subsequent to year-end, forecasted performance of the investee, and the general market condition in the geographic area or industry the investee operates in. Premiums and discounts are amortized or accreted over the life of the related held-to-maturity security as an adjustment to yield using the effective-interest method. Such amortization and accretion is included in the “interest income” line item in the statements of operations. Interest income is recognized when earned.
Fair Value Measurements	Fair Value Measurements (Restated, see Note 2, First Amendment) FASB ASC Topic 820 “Fair Value Measurements and Disclosures” (“ASC 820”) defines fair value, the methods used to measure fair value and the expanded disclosures about fair value measurements. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between the buyer and the seller at the measurement date. In determining fair value, the valuation techniques consistent with the market approach, income approach and cost approach shall be used to measure fair value. ASC 820 establishes a fair value hierarchy for inputs, which represent the assumptions used by the buyer and seller in pricing the asset or liability. These inputs are further defined as observable and unobservable inputs. Observable inputs are those that buyer and seller would use in pricing the asset or liability based on market data obtained from sources independent of the Company. Unobservable inputs reflect the Company’s assumptions about the inputs that the buyer and seller would use in pricing the asset or liability developed based on the best information available in the circumstances. The fair value of the Public Warrants issued in connection with the initial public offering and Private Placement Warrants were initially measured at fair value using a Monte Carlo simulation model and subsequently, the fair value of the Private Placement Warrants have been estimated using a Monte Carlo simulation model each measurement date. The fair value of Public Warrants issued in connection with the initial public offering has been measured based on the listed market price of such warrants since February 5 th The fair value hierarchy is categorized into three levels based on the inputs as follows: Level 1 — Valuations based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. Valuation adjustments and block discounts are not being applied. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these securities does not entail a significant degree of judgment. Level 2 — Valuations based on (i) quoted prices in active markets for similar assets and liabilities, (ii) quoted prices in markets that are not active for identical or similar assets, (iii) inputs other than quoted prices for the assets or liabilities, or (iv) inputs that are derived principally from or corroborated by market through correlation or other means. Level 3 — Valuations based on inputs that are unobservable and significant to the overall fair value measurement. The fair value of the Company’s certain assets and liabilities, which qualify as financial instruments under ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the balance sheet. The fair values of cash and cash equivalents, prepaid assets, accounts payable and accrued expenses, due to related parties are estimated to approximate the carrying values as of December 31, 2020 due to the short maturities of such instruments. The Company’s warrant liability is based on a valuation model utilizing management judgment and pricing inputs from observable and unobservable markets with less volume and transaction frequency than active markets. Significant deviations from these estimates and inputs could result in a material change in fair value. The fair value of the warrant liability is classified as level 3. See Note 7 for additional information on assets and liabilities measured at fair value.
Derivative Financial Instruments	Derivative Financial Instruments (Restated, see Note 2, First Amendment) The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging”. Derivative instruments are recorded at fair value on the grant date and re-valued at each reporting date, with changes in the fair value reported in the statements of operations. Derivative assets and liabilities are classified on the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date. The Company has determined the warrants are a derivative instrument. FASB ASC 470-20, Debt with Conversion and Other Options addresses the allocation of proceeds from the issuance of convertible debt into its equity and debt components. The Company applies this guidance to allocate IPO proceeds from the Units between Class A ordinary shares and warrants, using the residual method by allocating IPO proceeds first to fair value of the warrants and then the Class A ordinary shares.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. At December 31, 2020, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.
Ordinary Shares Subject to Possible Redemption	Ordinary Shares Subject to Possible Redemption (Restated, see Note 2, Second Amendment) All of the 57,500,000 Public Shares contain a redemption feature which allows for their redemption in connection with the Company’s liquidation, if there is a shareholder vote or tender offer in connection with the Business Combination and in connection with certain amendments to the Company’s amended and restated memorandum and articles of association. In accordance with SEC and its staff’s guidance on redeemable equity instruments, which has been codified in ASC 480-10-S99, redemption provisions not solely within the control of the Company require ordinary shares subject to redemption to be classified outside of permanent equity. Therefore, all Public Shares have been classified outside of permanent equity. In accordance with ASC 480-10-S99-3A(15), there are two alternative methods that an entity can apply when subsequently measuring redeemable public shares: 1. Remeasure the redeemable public shares to their redemption amount immediately as if the end of the first reporting period after the IPO was the redemption date. 2. Accrete changes in the difference between the initial carrying amount and the redemption amount from the IPO date to the redemption date. The Company has decided to apply the first method above. As of December 31, 2020, the Class A ordinary shares reflected on the balance sheet are reconciled in the following table: Gross proceeds from IPO $ 575,000,000 Less: Proceeds allocated to Public Warrants (14,566,667 ) Class A ordinary shares issuance costs (31,396,824 ) Plus: Accretion of carrying value to redemption value 45,973,459 Class A ordinary shares subject to possible redemption $ 575,009,968
Net Loss Per Ordinary Share	Net Loss Per Ordinary Share (Restated, see Note 2, Amendment 2) The Company has two classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Earnings and losses are shared pro rata between the two classes of shares. The 28,166,667 potential ordinary shares for outstanding warrants to purchase the Company’s shares were excluded from diluted earnings per share for the period from October 7, 2020 (inception) through December 31, 2020 because the warrants are contingently exercisable, and the contingencies have not yet been met. As a result, diluted net loss per ordinary share is the same as basic net loss per ordinary share for the period presented. The table below presents a reconciliation of the numerator and denominator used to compute basic and diluted net loss per share for each class of ordinary shares: For the period from Class A Class B Basic and diluted net loss per share: Numerator: Allocation of net loss $ (1,568,125 ) $ (2,948,757 ) Denominator: Weighted-average shares outstanding 6,764,706 12,720,588 Basic and diluted net loss per share $ (0.23 ) $ (0.23 )
Offering Costs	Offering Costs The Company complies with the requirements of the ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A - “Expenses of Offering”. Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to the IPO. Offering costs are allocated to the separable financial instruments issued in the IPO based on a relative fair value basis compared to total proceeds received. Offering costs associated with warrant liabilities is expensed, and offering costs associated with the Class A ordinary share are charged to the shareholders’ equity.
Income Taxes	Income Taxes The Company accounts for income taxes under ASC 740 Income Taxes (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is a Cayman Islands exempted company and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States.
Recent Accounting Pronouncements	Recent Accounting Pronouncements Management does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.

Restatement of previously iss_2

Restatement of previously issued financial statements (Tables)	3 Months Ended
	Dec. 31, 2020
Condensed Financial Information Disclosure [Abstract]
Schedule of the restatement on each financial statement	As Adjustment As Restated Balance Sheet at December 21, 2020 Warrant Liability $ - $ 26,786,667 $ 26,786,667 Class A ordinary shares subject to possible redemption 551,300,880 (26,786,670 ) 524,514,210 Class A ordinary shares 237 268 505 Additional paid-in capital 5,009,562 815,795 5,825,357 Accumulated deficit $ (11,233 ) $ (816,060 ) $ (827,293 ) Balance Sheet at December 31, 2020 Warrant Liability $ - $ 30,461,667 $ 30,461,667 Class A ordinary shares subject to possible redemption, 551,286,290 (30,461,670 ) 520,824,620 Class A ordinary shares 237 305 542 Additional paid-in capital 5,024,151 4,490,758 9,514,909 Accumulated deficit $ (25,822 ) $ (4,491,060 ) $ (4,516,882 ) Statement of Operations for the period from October 7, 2020 (inception) through December 31, 2020 Unrealized loss on change in fair value of warrants $ - $ (3,675,000 ) $ (3,675,000 ) Warrant issuance costs - (816,060 ) (816,060 ) Net loss $ (25,822 ) $ (4,491,060 ) $ (4,516,882 ) Weighted average shares outstanding, basic and diluted 14,653,813 315,137 14,968,950 Basic and diluted net loss per share $ (0.00 ) $ (0.30 ) $ (0.30 ) Statement of Cash Flows for the period from October 7, 2020 (inception) through December 31, 2020 Cash Flows from Operating Activities: Net loss $ (25,822 ) $ (4,491,060 ) $ (4,516,882 ) Unrealized loss on change in fair value of warrants - 3,675,000 3,675,000 Warrant issuance costs $ - $ 816,060 $ 816,060 As Adjustments As Restated Balance Sheet as of December 21, 2020 (as revised in footnote 2 per Form 10-K/A filed on May 17, 2021) Ordinary share subject to possible redemption ($) $ 524,514,210 $ 50,485,790 $ 575,000,000 Ordinary shares Class A, $0.0001 par value 505 (505 ) - Additional paid-in capital 5,825,357 (5,825,357 ) - Accumulated deficit (827,293 ) (44,659,928 ) (45,487,221 ) Total shareholders’ equity $ 5,000,007 $ (50,485,790 ) $ (45,485,783 ) Number of shares subject to redemption 52,451,421 5,048,579 57,500,000 Balance Sheet at December 31, 2020 Class A ordinary shares subject to possible redemption $ 520,824,620 $ 54,185,348 $ 575,009,968 Class A ordinary shares 542 (542 ) - Additional paid-in capital 9,514,909 (9,514,909 ) - Accumulated deficit (4,516,882 ) (44,669,897 ) (49,186,779 ) Total shareholders’ equity $ 5,000,007 $ (54,185,348 ) $ (49,185,341 ) Statement of Operations for the period from October 7, 2020 (inception) through December 31, 2020 Basic and diluted weighted average shares outstanding, ordinary shares subject to redemption - 6,764,706 6,764,706 Basic and diluted net loss per share $ - $ (0.23 ) $ (0.23 ) Basic and diluted weighted average shares outstanding, ordinary shares 14,968,950 (2,248,362 ) 12,720,588 Basic and diluted net loss per share $ (0.30 ) $ 0.07 $ (0.23 ) Statement of Shareholders’ Equity for the period from October 7, 2020 (inception) through December 31, 2020 Remeasurement in Class A ordinary shares to redemption value $ (520,824,620 ) $ 474,851,161 $ (45,973,459 ) Class A ordinary shares 542 (542 ) - Additional paid-in capital 9,514,909 (9,514,909 ) - Accumulated deficit (4,516,882 ) (44,669,897 ) (49,186,779 ) Total shareholders’ equity $ 5,000,007 $ (54,185,348 ) $ (49,185,341 ) Statement of Cash Flows for the period from October 7, 2020 (inception) through December 31, 2020 Initial value of Class A ordinary shares subject to possible redemption $ 524,514,210 $ 4,522,299 $ 529,036,509 Remeasurement in Class A ordinary shares to redemption value $ (3,689,590 ) $ 49,663,049 $ 45,973,459

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Tables)	3 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
Schedule of class A ordinary shares reflected on the balance sheet	Gross proceeds from IPO $ 575,000,000 Less: Proceeds allocated to Public Warrants (14,566,667 ) Class A ordinary shares issuance costs (31,396,824 ) Plus: Accretion of carrying value to redemption value 45,973,459 Class A ordinary shares subject to possible redemption $ 575,009,968
Schedule of basic and diluted net loss per share of ordinary shares	For the period from Class A Class B Basic and diluted net loss per share: Numerator: Allocation of net loss $ (1,568,125 ) $ (2,948,757 ) Denominator: Weighted-average shares outstanding 6,764,706 12,720,588 Basic and diluted net loss per share $ (0.23 ) $ (0.23 )

Recurring Fair Value Measurem_2

Recurring Fair Value Measurements (Tables)	3 Months Ended
	Dec. 31, 2020
Fair Value Disclosures [Abstract]
Schedule of assets and liabilities that were measured at fair value on a recurring basis	December 31, Quoted Significant Significant 2020 (Level 1) (Level 2) (Level 3) Assets: U.S. Money Market held in Trust Account $ 632 $ 632 $ - $ - U.S. Treasury Securities held in Trust Account 575,009,336 575,009,336 - - $ 575,009,968 $ 575,009,968 $ - $ - Liabilities: Private Placement Warrants 7,920,000 - - $ 7,920,000 Public Warrants 16,675,000 - - $ 16,675,000 Forward Purchase Warrants 5,866,667 - - $ 5,866,667 Warrant Liability $ 30,461,667 $ - $ - $ 30,461,667 December 31, Quoted Significant Significant 2020 (Level 1) (Level 2) (Level 3) Assets: U.S. Money Market held in Trust Account $ 632 $ 632 $ - $ - U.S. Treasury Securities held in Trust Account 575,009,336 575,009,336 - - $ 575,009,968 $ 575,009,968 $ - $ - Liabilities: Private Placement Warrants - - - $ 7,920,000 Public Warrants - - - $ 16,675,000 Forward Purchase Warrants - - - $ 5,866,667 $ 30,461,667 $ - $ - $ 30,461,667
Schedule of key inputs into the Monte Carlo simulation model and Black-Scholes Model	Input December 16, Risk-free interest rate 0.47 % Expected term (years) 5.75 Expected volatility 15.0 % Exercise price $ 11.50 Input December 31, Risk-free interest rate 0.46 % Expected term (years) 5.71 Expected volatility 15.0 % Exercise price $ 11.50
Schedule of changes in the fair value of warrant liabilities	Public Warrants Public Warrants Forward Purchase Warrants Fair value as of December 31, 2019 - - - Initial measurement on December 16, 2020 $ 7,020,000 $ 14,566,667 $ 5,200,000 Change in valuation inputs or other assumptions (1) $ 900,000 $ 2,108,333 $ 666,667 Fair value as of December 31, 2020 $ 7,920,000 $ 16,675,000 $ 5,866,667

Organization and Business Ope_2

Organization and Business Operations (Details) - USD ($)	Dec. 21, 2020	Dec. 21, 2020	Dec. 31, 2020
Organization and Business Operations (Details) [Line Items]
Price per unit (in Dollars per share)	$ 10	$ 10
Gross proceeds			$ 563,500,000
Share price (in Dollars per share)	$ 1.50	$ 1.50
Gross proceeds			13,500,000
Transaction costs	$ 32,212,884	$ 32,212,884
Underwriting discount			11,500,000
Deferred underwriting discount			20,125,000
Other offering costs			$ 587,884
Trust account per share (in Dollars per share)			$ 10
Dissolution expenses			$ 100,000
Assets Held-in-trust			1,425,919
Offering costs			25,000
Unsecured promissory note			222,583
Trust account			$ 1,425,919
Initial Business Combination [Member]
Organization and Business Operations (Details) [Line Items]
Initial business combination, description			initial Business Combinations having an aggregate fair market value of at least 80% of the value of the assets held in the Trust Account (excluding the deferred underwriting commissions and taxes payable on the interest earned on the Trust Account) at the time of the agreement to enter into the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act 1940, as amended (the “Investment Company Act”).
Net tangible assets			$ 5,000,001
Over-Allotment Option [Member]
Organization and Business Operations (Details) [Line Items]
Sale of stock (in Shares)		57,500,000	57,500,000
Over-Allotment Option [Member] | Warrant [Member]
Organization and Business Operations (Details) [Line Items]
Gross proceeds		$ 575,000,000
IPO [Member]
Organization and Business Operations (Details) [Line Items]
Sale of stock (in Shares)		7,500,000	7,500,000
Price per unit (in Dollars per share)	$ 10	$ 10	$ 10
Gross proceeds	$ 575,000,000
Private Placement [Member]
Organization and Business Operations (Details) [Line Items]
Sale of stock (in Shares)		9,000,000	9,000,000
Gross proceeds		$ 13,500,000

Restatement of previously iss_3

Restatement of previously issued financial statements (Details)	3 Months Ended
	Dec. 31, 2020USD ($)$ / sharesshares
Restatement of previously issued financial statements (Details) [Line Items]
Share redemption value (in Dollars per share) | $ / shares	$ 10
Net tangible assets (in Dollars) | $	$ 5,000,001
Warrant [Member]
Restatement of previously issued financial statements (Details) [Line Items]
Warrants issued	19,166,667
Private Placement [Member]
Restatement of previously issued financial statements (Details) [Line Items]
Warrants issued	9,000,000
Forward Purchase Warrants [Member]
Restatement of previously issued financial statements (Details) [Line Items]
Warrants issued	6,666,667

Restatement of previously iss_4

Restatement of previously issued financial statements (Details) - Schedule of the restatement on each financial statement - USD ($)	3 Months Ended
	Dec. 31, 2020	Dec. 21, 2020
As Previously Reported [Member]
Condensed Financial Statements, Captions [Line Items]
Warrant Liability
Class A ordinary shares subject to possible redemption	551,286,290	551,300,880
Class A ordinary shares	237	237
Additional paid-in capital	5,024,151	5,009,562
Accumulated deficit	(25,822)	(11,233)
Statement of Operations for the period from October 7, 2020 (inception) through December 31, 2020
Unrealized loss on change in fair value of warrants
Warrant issuance costs
Net loss	(25,822)
Unrealized loss on change in fair value of warrants
Warrant issuance costs
Weighted average shares outstanding, basic and diluted (in Shares)	14,653,813
Basic and diluted net loss per share (in Dollars per share)	$ 0
Ordinary share subject to possible redemption ($)		524,514,210
Ordinary shares Class A, $0.0001 par value		505
Additional paid-in capital	$ 9,514,909	5,825,357
Accumulated deficit	(4,516,882)	(827,293)
Total shareholders’ equity	5,000,007	$ 5,000,007
Number of shares subject to redemption (in Shares)		52,451,421
Balance Sheet at December 31, 2020
Class A ordinary shares subject to possible redemption	520,824,620
Class A ordinary shares	$ 542
Statement of Operations for the period from October 7, 2020 (inception) through December 31, 2020
Basic and diluted weighted average shares outstanding, ordinary shares subject to redemption (in Shares)
Basic and diluted net loss per share (in Dollars per share)
Basic and diluted weighted average shares outstanding, ordinary shares (in Shares)	14,968,950
Basic and diluted net loss per share (in Dollars per share)	$ (0.30)
Statement of Shareholders’ Equity for the period from October 7, 2020 (inception) through December 31, 2020
Remeasurement in Class A ordinary shares to redemption value	$ (520,824,620)
Statement of Cash Flows for the period from October 7, 2020 (inception) through December 31, 2020
Initial value of Class A ordinary shares subject to possible redemption	524,514,210
Remeasurement in Class A ordinary shares to redemption value	(3,689,590)
Adjustments [Member]
Condensed Financial Statements, Captions [Line Items]
Warrant Liability	30,461,667	$ 26,786,667
Class A ordinary shares subject to possible redemption	(30,461,670)	(26,786,670)
Class A ordinary shares	305	268
Additional paid-in capital	4,490,758	815,795
Accumulated deficit	(4,491,060)	(816,060)
Statement of Operations for the period from October 7, 2020 (inception) through December 31, 2020
Unrealized loss on change in fair value of warrants	(3,675,000)
Warrant issuance costs	(816,060)
Net loss	(4,491,060)
Unrealized loss on change in fair value of warrants	3,675,000
Warrant issuance costs	$ 816,060
Weighted average shares outstanding, basic and diluted (in Shares)	315,137
Basic and diluted net loss per share (in Dollars per share)	$ (0.30)
Ordinary share subject to possible redemption ($)		50,485,790
Ordinary shares Class A, $0.0001 par value		(505)
Additional paid-in capital	$ (9,514,909)	(5,825,357)
Accumulated deficit	(44,669,897)	(44,659,928)
Total shareholders’ equity	(54,185,348)	$ (50,485,790)
Number of shares subject to redemption (in Shares)		5,048,579
Balance Sheet at December 31, 2020
Class A ordinary shares subject to possible redemption	54,185,348
Class A ordinary shares	$ (542)
Statement of Operations for the period from October 7, 2020 (inception) through December 31, 2020
Basic and diluted weighted average shares outstanding, ordinary shares subject to redemption (in Shares)	6,764,706
Basic and diluted net loss per share (in Dollars per share)	$ (0.23)
Basic and diluted weighted average shares outstanding, ordinary shares (in Shares)	(2,248,362)
Basic and diluted net loss per share (in Dollars per share)	$ 0.07
Statement of Shareholders’ Equity for the period from October 7, 2020 (inception) through December 31, 2020
Remeasurement in Class A ordinary shares to redemption value	$ 474,851,161
Statement of Cash Flows for the period from October 7, 2020 (inception) through December 31, 2020
Initial value of Class A ordinary shares subject to possible redemption	4,522,299
Remeasurement in Class A ordinary shares to redemption value	49,663,049
As Restated [Member]
Condensed Financial Statements, Captions [Line Items]
Warrant Liability	30,461,667	$ 26,786,667
Class A ordinary shares subject to possible redemption	520,824,620	524,514,210
Class A ordinary shares	542	505
Additional paid-in capital	9,514,909	5,825,357
Accumulated deficit	(4,516,882)	(827,293)
Statement of Operations for the period from October 7, 2020 (inception) through December 31, 2020
Unrealized loss on change in fair value of warrants	(3,675,000)
Warrant issuance costs	(816,060)
Net loss	(4,516,882)
Unrealized loss on change in fair value of warrants	3,675,000
Warrant issuance costs	$ 816,060
Weighted average shares outstanding, basic and diluted (in Shares)	14,968,950
Basic and diluted net loss per share (in Dollars per share)	$ (0.30)
Ordinary share subject to possible redemption ($)		575,000,000
Ordinary shares Class A, $0.0001 par value
Additional paid-in capital
Accumulated deficit	(49,186,779)	(45,487,221)
Total shareholders’ equity	(49,185,341)	$ (45,485,783)
Number of shares subject to redemption (in Shares)		57,500,000
Balance Sheet at December 31, 2020
Class A ordinary shares subject to possible redemption	575,009,968
Class A ordinary shares
Statement of Operations for the period from October 7, 2020 (inception) through December 31, 2020
Basic and diluted weighted average shares outstanding, ordinary shares subject to redemption (in Shares)	6,764,706
Basic and diluted net loss per share (in Dollars per share)	$ (0.23)
Basic and diluted weighted average shares outstanding, ordinary shares (in Shares)	12,720,588
Basic and diluted net loss per share (in Dollars per share)	$ (0.23)
Statement of Shareholders’ Equity for the period from October 7, 2020 (inception) through December 31, 2020
Remeasurement in Class A ordinary shares to redemption value	$ (45,973,459)
Statement of Cash Flows for the period from October 7, 2020 (inception) through December 31, 2020
Initial value of Class A ordinary shares subject to possible redemption	529,036,509
Remeasurement in Class A ordinary shares to redemption value	$ 45,973,459

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Details)	3 Months Ended
	Dec. 31, 2020USD ($)shares
Accounting Policies [Abstract]
Fair value of liabilities | $	$ 3,700,000
Federal depository insurance coverage | $	$ 250,000
Public shares | shares	57,500,000
Purchase of outstanding warrants | shares	28,166,667

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Details) - Schedule of class A ordinary shares reflected on the balance sheet	3 Months Ended
	Dec. 31, 2020USD ($)
Schedule of class A ordinary shares reflected on the balance sheet [Abstract]
Gross proceeds from IPO	$ 575,000,000
Less:
Proceeds allocated to Public Warrants	(14,566,667)
Class A ordinary shares issuance costs	(31,396,824)
Plus:
Accretion of carrying value to redemption value	45,973,459
Class A ordinary shares subject to possible redemption	$ 575,009,968

Summary of Significant Accoun_5

Summary of Significant Accounting Policies (Details) - Schedule of basic and diluted net loss per share of ordinary shares	12 Months Ended
	Dec. 31, 2020USD ($)$ / sharesshares
Class A [Member]
Numerator:
Allocation of net loss | $	$ (1,568,125)
Denominator:
Weighted-average shares outstanding | shares	6,764,706
Basic and diluted net loss per share | $ / shares	$ (0.23)
Class B [Member]
Numerator:
Allocation of net loss | $	$ (2,948,757)
Denominator:
Weighted-average shares outstanding | shares	12,720,588
Basic and diluted net loss per share | $ / shares	$ (0.23)

Initial Public Offering (Detail

Initial Public Offering (Details) - $ / shares	1 Months Ended	3 Months Ended
	Dec. 21, 2020	Dec. 31, 2020	Oct. 08, 2020
Initial Public Offering (Details) [Line Items]
Price per share	$ 10
Share issued price		$ 11.50	$ 0.002
Over-Allotment Option [Member]
Initial Public Offering (Details) [Line Items]
Sale of units	57,500,000	57,500,000
Proposed Public Offering [Member]
Initial Public Offering (Details) [Line Items]
Sale of units	7,500,000	7,500,000
Price per share	$ 10	$ 10
Class A Ordinary Shares [Member]
Initial Public Offering (Details) [Line Items]
Share issued price		$ 11.50
Redemption of warrants, description		Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $10.00 Once the warrants become exercisable, the Company may redeem the outstanding warrants: ●in whole and not in part; ● at a price of $0.10 per warrant; upon a minimum of 30 days’ prior written notice of redemption; provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares, based on the redemption date and the “fair market value” (as defined below) of Class A ordinary shares except as otherwise described below; and ● if, and only if, the closing price of Class A ordinary shares equals or exceeds $10.00 per share, subject to adjustment, for any 20 trading days within the 30-trading day period ending three trading days before the Company sends the notice of redemption to the warrant holders; and ● if the closing price of the Class A ordinary shares for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders is less than $18.00 per share, subject to adjustment, the private placement warrants must also be concurrently called for redemption on the same terms as the outstanding public warrants, as described above.
Class A Ordinary Shares [Member] | Warrant [Member]
Initial Public Offering (Details) [Line Items]
Description of sale of stock		In addition, if (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination (excluding any issuance of forward purchase securities) at an issue price or effective issue price of less than $9.20 per Class A ordinary share (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and in the case of any such issuance to the Company’s initial shareholders or their affiliate, without taking into account any founder shares held by the Company’s initial shareholders or such affiliates, as applicable, prior to such issuance (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds (including from such issuances, the IPO and the sale of the forward purchase units), and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s Class A ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, then the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger prices described below under “Redemption of warrants when the price per Class A ordinary share equals or exceeds $18.00” and “Redemption of warrants when the price per Class A ordinary share equals or exceeds $10.00” will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price, and the $10.00 per share redemption trigger price described adjacent to the caption “Redemption of warrants when the price per Class A ordinary share equals or exceeds $10.00” will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price.
Redemption of warrants, description		Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $18.00 Once the warrants become exercisable, the Company may redeem the outstanding warrants: ●in whole and not in part; ●at a price of $0.01 per warrant; upon a minimum of 30 days’ prior written notice of redemption (the “30-day redemption period”); and ●if, and only if, the closing price of the Class A ordinary shares equals or exceeds $18.00 per share, subject to adjustment, for any 20 trading days within a 30-trading day period ending three business days before the Company sends the notice of redemption to the warrant holders.

Private Placement (Details)

Private Placement (Details) - USD ($)	1 Months Ended	3 Months Ended
	Dec. 21, 2020	Dec. 31, 2020
Private Placement (Details) [Line Items]
Redeem percentage		100.00%
Private Placement Warrant [Member]
Private Placement (Details) [Line Items]
Purchased an aggregate share	9,000,000	9,000,000
Warrants price per share		$ 1.50
Aggregate purchase price		$ 13,500,000

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)	Oct. 09, 2020	Oct. 08, 2020	Dec. 21, 2020	Dec. 31, 2020	Dec. 16, 2020
Related Party Transactions (Details) [Line Items]
Forfeiture of founder shares (in Shares)		1,875,000
Price per shares (in Dollars per share)			$ 10
Offering proceeds				$ 25,000
Due to related parties			$ 5,162	5,162
Working capital loans			$ 1,500,000
Convertible into warrants price (in Dollars per share)			$ 1.50
Administrative and support service expenses				10,000
Administrative services				$ 5,162
Price per share (in Dollars per share)		$ 0.002		$ 11.50
Forward Purchase Agreement [Member]
Related Party Transactions (Details) [Line Items]
Aggregate forward purchase units (in Shares)					10,000,000
Price per share (in Dollars per share)					$ 10
Aggregate amount					$ 100,000,000
Promissory Note [Member]
Related Party Transactions (Details) [Line Items]
Borrowed amount			$ 222,583
Founder Shares [Member]
Related Party Transactions (Details) [Line Items]
Purchase price		$ 25,000
Common stock, par value (in Dollars per share)		$ 0.002
Price per shares (in Dollars per share)				12
Over-Allotment Option [Member]
Related Party Transactions (Details) [Line Items]
Forfeiture of founder shares (in Shares)			1,875,000
IPO [Member]
Related Party Transactions (Details) [Line Items]
Price per shares (in Dollars per share)			$ 10	$ 10
Agreed to loan	$ 300,000
Offering proceeds	$ 1,000,000
Private Placement [Member]
Related Party Transactions (Details) [Line Items]
Purchase price				$ 13,500,000
Aggregate amount					$ 300,000,000
Class B Ordinary Shares [Member]
Related Party Transactions (Details) [Line Items]
Common stock, par value (in Dollars per share)		$ 0.0001		$ 0.0001
Issuance of common stock to founder (in Shares)		14,375,000
Class A Ordinary Shares [Member]
Related Party Transactions (Details) [Line Items]
Common stock, par value (in Dollars per share)				0.0001
Price per share (in Dollars per share)				$ 11.50
Class A Ordinary Shares [Member] | Forward Purchase Agreement [Member]
Related Party Transactions (Details) [Line Items]
Aggregate forward purchase units (in Shares)					30,000,000

Recurring Fair Value Measurem_3

Recurring Fair Value Measurements (Details)	3 Months Ended
	Dec. 31, 2020USD ($)
Recurring Fair Value Measurements (Details) [Line Items]
Short term investments, description	The Company considers all investments with original maturities of more than three months but less than one year to be short-term investments.
Warrant liability	$ 30,461,667
U S Money Market [Member]
Recurring Fair Value Measurements (Details) [Line Items]
Trust account	632
US Treasury Securities [Member]
Recurring Fair Value Measurements (Details) [Line Items]
Trust account	575,009,336
Forward Purchase Agreement [Member]
Recurring Fair Value Measurements (Details) [Line Items]
Estimate for deriving warrants liability	$ 200,000,000

Recurring Fair Value Measurem_4

Recurring Fair Value Measurements (Details) - Schedule of assets and liabilities that were measured at fair value on a recurring basis	Dec. 31, 2020USD ($)
Assets:
U.S. Money Market held in Trust Account	$ 632
U.S. Treasury Securities held in Trust Account	575,009,336
Fair Value of assets	575,009,968
Liabilities:
Private Placement Warrants
Public Warrants
Forward Purchase Warrants
Private Placement Warrants	7,920,000
Public Warrants	16,675,000
Forward Purchase Warrants	5,866,667
Warrant Liability	30,461,667
Quoted Prices in Active Markets (Level 1) [Member]
Assets:
U.S. Money Market held in Trust Account	632
U.S. Treasury Securities held in Trust Account	575,009,336
Fair Value of assets	575,009,968
Liabilities:
Private Placement Warrants
Public Warrants
Forward Purchase Warrants
Private Placement Warrants
Public Warrants
Forward Purchase Warrants
Warrant Liability
Significant Other Observable Inputs (Level 2) [Member]
Assets:
U.S. Money Market held in Trust Account
U.S. Treasury Securities held in Trust Account
Fair Value of assets
Liabilities:
Private Placement Warrants
Public Warrants
Forward Purchase Warrants
Private Placement Warrants
Public Warrants
Forward Purchase Warrants
Warrant Liability
Significant Other Unobservable Inputs (Level 3) [Member]
Assets:
U.S. Money Market held in Trust Account
U.S. Treasury Securities held in Trust Account
Fair Value of assets
Liabilities:
Private Placement Warrants	7,920,000
Public Warrants	16,675,000
Forward Purchase Warrants	5,866,667
Private Placement Warrants	7,920,000
Public Warrants	16,675,000
Forward Purchase Warrants	5,866,667
Warrant Liability	$ 30,461,667

Recurring Fair Value Measurem_5

Recurring Fair Value Measurements (Details) - Schedule of key inputs into the Monte Carlo simulation model and Black-Scholes Model - $ / shares	1 Months Ended	3 Months Ended
	Dec. 16, 2020	Dec. 31, 2020
Schedule of key inputs into the Monte Carlo simulation model and Black-Scholes Model [Abstract]
Risk-free interest rate	0.47%	0.46%
Expected term (years)	5 years 9 months	5 years 259 days
Expected volatility	15.00%	15.00%
Exercise price (in Dollars per share)	$ 11.50	$ 11.50

Recurring Fair Value Measurem_6

Recurring Fair Value Measurements (Details) - Schedule of changes in the fair value of warrant liabilities	3 Months Ended
	Dec. 31, 2020USD ($)
Private Placement Warrants [Member]
Recurring Fair Value Measurements (Details) - Schedule of changes in the fair value of warrant liabilities [Line Items]
Fair value as of December 31, 2019
Initial measurement on December 16, 2020	7,020,000
Change in valuation inputs or other assumptions	900,000	[1]
Fair value as of December 31, 2020	7,920,000
Public Warrants [Member]
Recurring Fair Value Measurements (Details) - Schedule of changes in the fair value of warrant liabilities [Line Items]
Fair value as of December 31, 2019
Initial measurement on December 16, 2020	14,566,667
Change in valuation inputs or other assumptions	2,108,333	[1]
Fair value as of December 31, 2020	16,675,000
Forward Purchase Warrants [Member]
Recurring Fair Value Measurements (Details) - Schedule of changes in the fair value of warrant liabilities [Line Items]
Fair value as of December 31, 2019
Initial measurement on December 16, 2020	5,200,000
Change in valuation inputs or other assumptions	666,667	[1]
Fair value as of December 31, 2020	$ 5,866,667
[1]	Changes in valuation inputs or other assumptions are recognized in change in fair value of warrant liabilities in the Statement of Operations.

Commitments (Details)

Commitments (Details)	1 Months Ended
	Dec. 21, 2020USD ($)shares
Commitments (Details) [Line Items]
Underwriting discount amount	$ 11,500,000
Deferred underwriting percentage	3.50%
Gross proceeds value	$ 20,125,000
IPO [Member]
Commitments (Details) [Line Items]
Additional Units to cover over-allotment (in Shares) | shares	7,500,000

Shareholders' Equity (Details)

Shareholders' Equity (Details) - USD ($)	Oct. 08, 2020	Dec. 21, 2020	Dec. 31, 2020
Shareholders' Equity (Details) [Line Items]
Preferred stock, shares authorized			5,000,000
Preferred stock, par value (in Dollars per share)			$ 0.0001
Sponsor paid amount (in Dollars)	$ 25,000
price per share (in Dollars per share)	$ 0.002		$ 11.50
Shares subject to forfeited shares	1,875,000
Description of redeem public warrants			In the case that additional Class A ordinary shares or equity-linked securities are issued or deemed issued in connection with the initial Business Combination, the number of Class A ordinary shares issuable upon conversion of all founder shares will equal, in the aggregate, 20% of the total number of Class A ordinary shares outstanding after such conversion (after giving effect to any redemptions of Class A ordinary shares by public shareholders), including the total number of Class A ordinary shares issued, or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial Business Combination (including the forward purchase shares but not the forward purchase warrants), excluding any Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, or to be issued, to any seller in the initial Business Combination and any Private Placement Warrants issued to the Sponsor, officers or directors upon conversion of Working Capital Loans; provided that such conversion of founder shares will never occur on a less than one-for-one basis.
Conversion percentage			20.00%
Sponsor [Member]
Shareholders' Equity (Details) [Line Items]
Ordinary shares, par value (in Dollars per share)	$ 0.0001
Sponsor [Member]
Shareholders' Equity (Details) [Line Items]
Shares subject to forfeited shares	1,875,000
Over-Allotment Option [Member]
Shareholders' Equity (Details) [Line Items]
Shares subject to forfeited shares		1,875,000
Class A Ordinary Shares [Member]
Shareholders' Equity (Details) [Line Items]
Ordinary shares, shares authorized			500,000,000
Ordinary shares, par value (in Dollars per share)			$ 0.0001
Shares subject to possible redemption			57,500,000
price per share (in Dollars per share)			$ 11.50
Ordinary shares, shares issued
Class B Ordinary Shares [Member]
Shareholders' Equity (Details) [Line Items]
Ordinary shares, shares authorized			50,000,000
Ordinary shares, par value (in Dollars per share)	$ 0.0001		$ 0.0001
Ordinary shares offering cost	14,375,000
Ordinary shares, shares issued			14,375,000